The Iranian Cancer Diagnostic Probe (CDP) has been designed and manufactured by Dr. Abdolahad, faculty member of College of Engineering, University of Tehran, and his team. This device was developed with the supports of Iran Nanotechnology Innovation Council (INIC) succeeded in creating a technology for detecting cancerous margins and producing a CDP device. They finally developed their MVP and commercialized it.
The CDP is a medical device, which can determine the extent of metastasis and spread of a cancerous tumor in women’s breasts. It can detect the margin of the breast cancer and help remove cancerous outgrowths with high precision. The cancer margin is the edge or border of the tissue removed in cancer surgery, where cancerous cells could still exist and lead to later recurrence of the disease.
The existing method uses frozen sections and it takes about an hour to detect margin of cancer. However, the Iranian CDP can reduce that time to 15 seconds. The sensitivity of this device has been reported at over 97 percent. Iranian surgeons have been using the device for two years.
After visiting the functionality of the device, the Indian delegation indicated its willingness to purchase the equipment and use it in 10 hospitals.
January 15, 2023
Agreements
Comments
127
0 
Printable